Capecitabine combined with immunotherapy as maintenance therapy improves survival in recurrent/metastatic nasopharyngeal carcinoma: a retrospective cohort study.

Br J Cancer · 2026 · PMC12859054 · PMID 41398389

Europe PMC DOI

hedged sentence

0.0560

closest p · 1.1× alpha

0.0560

boldest claim

The sentences

a favorable trendp = 0.056so close (0.05 < p ≤ 0.1)

For OS, a favorable trend was observed in the younger subgroup (median OS, not reached vs. not reached; p = 0.056, Fig.

also in 1,335 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.